A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies
CRISPR Therapeutics
CRISPR Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
Thomas Jefferson University
Takeda
Incyte Corporation
Massachusetts General Hospital
Massachusetts General Hospital
Columbia University
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Brown University
Acerta Pharma BV
Amgen
University Health Network, Toronto
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
City of Hope Medical Center
Case Comprehensive Cancer Center
University of Arizona
Novartis
UNC Lineberger Comprehensive Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Stanford University
Constellation Pharmaceuticals
National Institutes of Health Clinical Center (CC)
AbbVie
Wugen, Inc.
Bristol-Myers Squibb
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University Health Network, Toronto
Cancer Trials Ireland
Masonic Cancer Center, University of Minnesota
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Masonic Cancer Center, University of Minnesota
Celgene
Novartis
Thomas Jefferson University
M.D. Anderson Cancer Center
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Shenzhen University General Hospital
University College, London